Difference between revisions of "Team:Duke/Human Practices"

 
(21 intermediate revisions by 2 users not shown)
Line 4: Line 4:
 
<div class="column full_size">
 
<div class="column full_size">
  
−
<p> Our group was able to focus on two different areas of Human Practices. One area of focus is on the patentability of an engineered bacteria while the other area of focus was on the societal impacts if the engineered bacteria were to be used in society. </p>
+
<p> Our group was able to focus on two different areas of Human Practices. One area of focus is on the patentability of an engineered bacteria while the other area of focus was on the societal impacts if the engineered bacteria were to be used in society. Our group was also part of an educational outreach program. </p>
 
</div>
 
</div>
  
  
 
<div class="column full_size">
 
<div class="column full_size">
−
<h2> Overview of the Projects</h2>
+
<h2> Our Projects</h2>
−
<br>
+
<br>  
−
<h3> An Overview and Analysis of the Societal Impacts of Taxol Biosynthesis in the United States </h3>
+
<h3> An Overview and Analysis of the Societal Impacts of Taxol Biosynthesis in the United States</h3>
−
<p>With a place on the World Health Organization’s Model List of Essential Medicines1,
+
<p> For more information on our Societal Impact Project click <a href="https://2016.igem.org/Team:Duke/Integrated_Practices"> here! </a></p>
−
Taxol is undeniably indispensable in treating cancer. Because of its demanding production
+
<br><br>
−
process, Taxol is expensive and in short supply. Resultantly, access is decreased for people
+
−
nationally and globally because of limitations based on treatment primarily stemming from high
+
−
costs, inaccessibility. With the optimization of Taxol biosynthesis, Taxol would become much
+
−
simpler and cheaper to produce, and would be available in greater quantity and ostensibly at a
+
−
decreased price. The immediate societal and economic impacts beyond this decrease in
+
−
production cost are much more nebulous, with cost and accessibility remaining major barriers to
+
−
cancer treatment in the United States.</p>
+
−
 
+
 
<h3> Patenting a New Form of Taxol Fermentation </h3>
 
<h3> Patenting a New Form of Taxol Fermentation </h3>
−
<p>Taxol, also known as pacilitaxel, is a widely used chemotherapy drug typically
+
<p> For more information on our Patenting Project click <a href="https://2016.igem.org/Team:Duke/HP/Silver"> here! </a></p>
−
extracted from the Yew tree. Mere extraction, however, does not yield sustainable returns
+
<br> <br>
−
because too-frequent extraction involves destroying the Yew tree source. Demand for Taxol
+
<h3> Educational Outreach </h3>
−
has outstripped supply, and scientists have turned to developing Taxol in plant cells followed
+
<p> For more information on our Patenting Project click <a href="https://2016.igem.org/Team:Duke/Engagement">here! </a></p>
−
by industrial fermentation. The Duke University International Genetically Engineered
+
<br> <br>
−
Machine Project looks to go a step further, by generating Taxol in bacteria cell cultures
+
−
instead of plant cell cultures. In order to use this invention to boost the market supply of
+
−
Taxol, the IGEM team will eventually need a corporate or non-profit partner, and this partner
+
−
will only be incentivized to participate if the IGEM team can offer exclusive licensing. Thus, the
+
−
success of IGEM’s new genetically engineered bacteria largely hinges on its patentability with
+
−
the United States Patent and Trademark Office. This report walks through the relevant patent
+
−
requirements, analyzes the case law, and comes to the conclusion that IGEM’s new genetically
+
−
engineered bacteria meets the conditions for successful patentability.</p>
+
−
 
+
  
 +
<!--
 
</div>
 
</div>
−
 
−
<!--
 
 
<div class="column half_size">
 
<div class="column half_size">
 
<h5>Some Human Practices topic areas </h5>
 
<h5>Some Human Practices topic areas </h5>
Line 58: Line 40:
 
</ul>
 
</ul>
 
</div>
 
</div>
−
 
  
 
<div class="column half_size">
 
<div class="column half_size">

Latest revision as of 05:10, 19 October 2016

Our group was able to focus on two different areas of Human Practices. One area of focus is on the patentability of an engineered bacteria while the other area of focus was on the societal impacts if the engineered bacteria were to be used in society. Our group was also part of an educational outreach program.

Our Projects


An Overview and Analysis of the Societal Impacts of Taxol Biosynthesis in the United States

For more information on our Societal Impact Project click here!



Patenting a New Form of Taxol Fermentation

For more information on our Patenting Project click here!



Educational Outreach

For more information on our Patenting Project click here!